Article
New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development
21 Nov 2023
Abstract excerpt
High Resolution Image Download MS PowerPoint Slide Biosynthetic engineering of bicyclic darobactins, selectively sealing the lateral gate of the outer membrane protein BamA, leads to active analogues, which are up to 128-fold more potent against Gram-negative pathogens compared to native counterparts. Because of their excellent antibacterial activity, darobactins represent one of the most promising new antibiotic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
